west virginia semaglutide side effect lawyer vomiting in law firm Semaglutide west virginia glp-1 glp-1 gastric intestinal obstruction attorney

Semaglutide (Wegovy) was tested in clinical trials and was found to help people lose an average of 21% of their starting weight after 72 weeks on the 7.2mg maintenance dose

The primary analysis used ANCOVA to estimate the effect of treatment (semaglutide vs

Blokhuis AM, Groen EJN, Koppers M, van den Berg LH, Pasterkamp RJ

(2023b, March 29)

However, the best candidate for Semaglutide is someone with a body-mass index (BMI) of 30 or above or those with a BMI of 27+ and have other health conditions like Type 2 diabetes or high blood pressure

Patients with type 2 diabetes on semaglutide are at very low risk for DKA, though rare case reports exist, particularly in the context of significant insulin dose reductions